FDA Warns of Medication Recall and Mix-Up: Potential Health Risks and Adverse Events

As one of the nation’s premier personal injury and mass tort law firms, we are capable of successfully handling all types of cases. If you or a loved one are injured due to the negligence of another, there is no better place to help advocate for your rights than Parker Waichman LLP.

FDA Warns of Medication Recall and Mix-Up: Potential Health Risks and Adverse Events

Two Medications Recalled Due to Labeling Error, Posing Serious Concerns for Patient Safety and Well-being

Fda warns of medication recall and mix-up: potential health risks and adverse events
FDA Warns of Medication Mix-Up

 

Two medications have been recalled by the FDA due to a major mix-up, leading to potential serious adverse events. This means that the medication you have in your medicine cabinet may not be the correct prescription. The FDA is concerned about the recall and the possibility of severe adverse events.

Two Different Medications Are Being Recalled

According to a press release from the FDA on June 13, The Harvard Drug Group, LLC has voluntarily issued a recall for one lot of Dronabinol Capsules, USP, 2.5 mg, and one lot of Ziprasidone Hydrochloride Capsules, 20 mg. These medications were sold under the Major Pharmaceuticals brand and distributed to wholesalers across the country on April 5.

Dronabinol is typically used to treat anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS), as well as nausea and vomiting in patients undergoing cancer chemotherapy.

Ziprasidone Hydrochloride is used to treat mood and mental disorders like schizophrenia and bipolar disorder.

The labels on the medications were mixed up.

dronabinol label U.S. FDA The recall was initiated after a customer reported that some cartons labeled as Ziprasidone Hydrochloride actually contained blister packages labeled as and containing Dronabinol. In response to this mix-up, the FDA issued a warning to consumers, especially older adults who are taking other medications that affect mental function, as they are particularly at risk for adverse reactions.

The FDA stated, “There is a reasonable probability that patients who mistakenly take Dronabinol Capsules, USP, 2.5 mg instead of Ziprasidone Hydrochloride, 20 mg capsules, can experience serious adverse events from 1) missing their ziprasidone dose and 2) taking an unexpected dose of Dronabinol.”

Missing a dose of Ziprasidone can worsen underlying health issues, potentially leading to mental illness instability with the possibility of self-harm or harm to others, which may require medical or psychiatric hospitalization.

Taking an unknown dose of Dronabinol can impair mental and physical abilities, worsening symptoms in patients with mental illness disorders and limiting their ability to safely perform activities such as driving or operating machinery.

How to Identify the Recalled Products

If you are currently taking either of these medications, it is important to confirm that you have received the correct prescription. The recalled Dronabinol capsules were packaged in blister packages of 10 by 10, totaling 100 doses. The recalled Ziprasidone Hydrochloride capsules were packaged in blister packages of 10 by 4, totaling 40 doses. Both medications have the lot number T04769.

Ziprasidone Hydrochloride capsules can be identified by their “lavender opaque cap and flesh opaque body.” They also have “RDY” and “356” printed on either side. Dronabinol capsules are white and have “M2” printed on them.

Consumers should discontinue use of the recalled medications.

A woman suspiciously answering a phone call Shutterstock The Harvard Drug Group will notify affected accounts by mail and arrange for the collection of the recalled products. Wholesalers, distributors, and retailers have been instructed to cease distribution of these products.

The FDA advises consumers to stop taking the recalled medications, return them to the place of purchase, and contact their healthcare provider. For specific questions regarding the recall, Sedgwick, Inc. can be reached via email at harvarddrug6068@sedgwick.com or by phone at 1-888-759-6904, Monday through Friday, between 8 a.m. and 5 p.m. Eastern Standard Time (EST).

Additionally, any adverse reactions should be reported through the FDA’s MedWatch Adverse Event Reporting program online, by mail, or by fax.

CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW

Parker Waichman LLP helps families recover monetary compensation for harm caused by dangerous products. For your free consultation, contact our national product injury law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
Free Consultation
Parker Waichman LLP
Are you inquiring about a new matter?
What type of accident did you have?
Please share a few details about your inquiry so we can connect you with the best person to assist you.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Related Video

4.8 from 549 Reviews

Client Reviews

Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.

I would recommend this firm to others. They were always quick to reply to any of my concerns, especially Shelly. She would answer my emails almost immediately. Highly professional and hassle free.
Kelly Wheeler
4 years ago
I have no photos, But the Lawyers are all nice and professional
Valetta Lovett
8 months ago
My experience with Parker Waichman was very professional and thorough from the first day I met with Gerard Ryan regarding my 9/11 claim. He explained in detail how the process works. The paralegals on my case were wonderful in instructing me how to gather my information and what to do at the different stages of the claim. I first worked with Christina Morace followed by Shelly Davis and concluded with Gina Viti. Each of these women was very detailed and helpful in instructing me on what I needed to do. They were very professional, kind and pleasant in all my telephone conversations with them. I must give extra credit to Christina the first person that communicated with me after meeting with Gerard. At a certain stage Shelly Davis began working with me and I found her to be very professional, pleasant and detailed in her instructions. The final stage of the claim I worked with Gina who was also very kind and pleasant. It would have been a pleasure if I had met them in person. Thanks to each of them my case was successfully filed and accepted. Thanks Parker Waichman. Great job Gerald, Christine, Shelly and Gina. No hesitation in recommending you.
Edna Ellis
2 years ago
Parker Waichman and my attorney kept me updated on all aspects of my case and how it was proceeding. I was pleased with the outcome.
Philip Ambrosino
2 months ago

Contact Us Today

If you or a loved one has been injured in an accident or have been injured by another party in some other way, we are here to stand up for your rights. Our personal injury attorneys have been representing injury victims and their families in Long Island and throughout the nation since the early 1980s.